QAELUM N.V., the
Belgium-based international specialist in medical quality monitoring and
analysis, announces it has completed an internal capital round of € 2 Mio. The
capital is provided by QAELUM’s current investors – including Gemma Frisius Fund
KU Leuven and business angel Marc Beuls – extended with Dr. Jan Schillebeeckx,
the current CMO of the company. The QAELUM team will use the investment to
further strengthen the management & sales structure and expand overseas. QAELUM
is a spin-off of the University Hospitals Leuven. Today, this link is
reinforced with Prof. Dr. Frank Rademakers joining QAELUM’s Board of Directors.
Showing confidence in the momentum of QAELUM
QAELUM has grown fast since 2012, when it spun out
from the University Hospitals Leuven, Belgium. In only four years, QAELUM
successively launched its total quality monitoring (TQM) solutions (tqm|DOSE,
tqm|QBOOK, tqm|BASELINE, etc.). QAELUM’s integrated software suite monitors,
analyses and improves a range of quality aspects related to patient radiation
dose. In addition, it guarantees maximum safety of patients and staff in
medical imaging departments. Other milestones are the agreements with FUJIFILM
and AGFA Healthcare to operate as QAELUM distributors with sales teams
promoting and selling tqm|DOSE internationally.
Luc Vandenbroucke, Chairman of QAELUM Board of
Directors: “Today QAELUM announces a new milestone with an internal € 2 Mio investment
round. I welcome the additional funds as a token of confidence the present
shareholders show in the future of QAELUM. These funds will be used mainly to
strengthen the management & sales structureand support the geographical expansion.”
Strengthened management team and overseas expansion
The internal investment round primarily includes
funds from current shareholders Gemma Frisius Fund KU Leuven, business angel
Marc Beuls and the other QAELUM shareholders - extended with Dr. Jan
Schillebeeckx, CMO of the company since 2013. Dr. Schillebeeckx is a key
opinion leader in the field of medical imaging and a European pioneer in
PACS and Teleradiology. He is also stakeholder for eHealth at the European
Commission. Earlier on he headed the medical imaging department at the Imelda
Hospital (Bonheiden, Belgium) for 23 years.
QAELUM welcomes Prof. Dr. Frank Rademakers as a new
member of its Board of Directors. This appointment illustrates the strengthened
collaboration with the University Hospitals Leuven, from which QAELUM originally
has spun out from.
CEO Jurgen Jacobs: “I see the internal investment
round as a confirmation of the exceptional achievements realised by the entire
QAELUM team. The investors support our business strategy for the coming years.
We will extend our management team and strengthen our sales force. We are going
to increase local presence in key EMEA regions and start gaining foothold in hospitals
outside Europe and Middle East. In general, we sense a growing awareness of medical
radiation and associated risks. Furthermore, medical imaging departments need
to adhere to a number of accreditation and auditing obligations. Our unique offering
converts the burden of lengthy manual quality evaluations into a valuable tool
for continuous quality improvement. After obtaining CE class IIb classification
for the EU market, QAELUM software has now also been approved for use in the US
and Canada.”
Source & Image Credit: QAELUM N.V.
